Patrick J. Nolan

Array ( [id] => 1366713 [patent_doc_number] => 06562344 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality' [patent_app_type] => B1 [patent_app_number] => 08/437884 [patent_app_country] => US [patent_app_date] => 1995-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 50 [patent_no_of_words] => 15600 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562344.pdf [firstpage_image] =>[orig_patent_app_number] => 08437884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730282 [patent_doc_number] => 05670627 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies' [patent_app_type] => 1 [patent_app_number] => 8/435680 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11560 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670627.pdf [firstpage_image] =>[orig_patent_app_number] => 435680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4370190 [patent_doc_number] => 06274711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Purified mammalian CTLA-8 antigens and related reagents' [patent_app_type] => 1 [patent_app_number] => 8/432994 [patent_app_country] => US [patent_app_date] => 1995-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20773 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274711.pdf [firstpage_image] =>[orig_patent_app_number] => 432994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4097161 [patent_doc_number] => 06099846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Enhancement of B cell lymphoma and tumor resistance using idiotype/cytokine conjugates' [patent_app_type] => 1 [patent_app_number] => 8/416787 [patent_app_country] => US [patent_app_date] => 1995-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 4318 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/099/06099846.pdf [firstpage_image] =>[orig_patent_app_number] => 416787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770850 [patent_doc_number] => 05807714 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Method of production of antigen-specific glycosylation inhibiting factor' [patent_app_type] => 1 [patent_app_number] => 8/416336 [patent_app_country] => US [patent_app_date] => 1995-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 19143 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807714.pdf [firstpage_image] =>[orig_patent_app_number] => 416336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995779 [patent_doc_number] => 05922598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Reducing tissue immunogenicity by induction of apoptosis' [patent_app_type] => 1 [patent_app_number] => 8/409518 [patent_app_country] => US [patent_app_date] => 1995-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2086 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922598.pdf [firstpage_image] =>[orig_patent_app_number] => 409518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4079688 [patent_doc_number] => 06054280 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Methods for diagnosis and treatment of PH domain signal transduction disorders' [patent_app_type] => 1 [patent_app_number] => 8/407165 [patent_app_country] => US [patent_app_date] => 1995-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23433 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054280.pdf [firstpage_image] =>[orig_patent_app_number] => 407165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1419657 [patent_doc_number] => 06514942 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Methods and compositions for stimulating T-lymphocytes' [patent_app_type] => B1 [patent_app_number] => 08/403459 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 29 [patent_no_of_words] => 33975 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514942.pdf [firstpage_image] =>[orig_patent_app_number] => 08403459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3656992 [patent_doc_number] => 05648072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor' [patent_app_type] => 1 [patent_app_number] => 8/402667 [patent_app_country] => US [patent_app_date] => 1995-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11792 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648072.pdf [firstpage_image] =>[orig_patent_app_number] => 402667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1340560 [patent_doc_number] => 06586222 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Recombinant PR-3 and compositions thereof' [patent_app_type] => B1 [patent_app_number] => 08/395456 [patent_app_country] => US [patent_app_date] => 1995-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 31178 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586222.pdf [firstpage_image] =>[orig_patent_app_number] => 08395456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3757715 [patent_doc_number] => 05843693 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Assay method for screening for inhibitors of proTNF conversion' [patent_app_type] => 1 [patent_app_number] => 8/394600 [patent_app_country] => US [patent_app_date] => 1995-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 28208 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 233 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843693.pdf [firstpage_image] =>[orig_patent_app_number] => 394600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693694 [patent_doc_number] => 05679641 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Peptides of human P53 protein for use in human T cell response inducing compositions, and human P53 protein-specific cytotoxic t-lymphocytes' [patent_app_type] => 1 [patent_app_number] => 8/338634 [patent_app_country] => US [patent_app_date] => 1995-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10195 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679641.pdf [firstpage_image] =>[orig_patent_app_number] => 338634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6241339 [patent_doc_number] => 20020044937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'PROTEIN-POLYCATION CONJUGATES' [patent_app_type] => new [patent_app_number] => 08/380200 [patent_app_country] => US [patent_app_date] => 1995-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11786 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20020044937.pdf [firstpage_image] =>[orig_patent_app_number] => 08380200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3734356 [patent_doc_number] => 05753228 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies' [patent_app_type] => 1 [patent_app_number] => 8/349840 [patent_app_country] => US [patent_app_date] => 1994-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5306 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753228.pdf [firstpage_image] =>[orig_patent_app_number] => 349840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4041183 [patent_doc_number] => 05911969 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Pretargeting protocols for enhanced localization of active agents to target sites' [patent_app_type] => 1 [patent_app_number] => 8/329617 [patent_app_country] => US [patent_app_date] => 1994-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19000 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/911/05911969.pdf [firstpage_image] =>[orig_patent_app_number] => 329617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4318974 [patent_doc_number] => 06331298 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Wound healing and treatment of fibrotic disorders' [patent_app_type] => 1 [patent_app_number] => 8/307640 [patent_app_country] => US [patent_app_date] => 1994-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3353 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331298.pdf [firstpage_image] =>[orig_patent_app_number] => 307640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3923755 [patent_doc_number] => 05914312 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Pretargeting methods and compounds' [patent_app_type] => 1 [patent_app_number] => 8/297429 [patent_app_country] => US [patent_app_date] => 1994-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19019 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914312.pdf [firstpage_image] =>[orig_patent_app_number] => 297429 [rel_patent_id] =>[rel_patent_doc_number] =>)